Clinical Trial Update: Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of Sorafenib plus Capecitabine (SorCape) in previously treated metastatic colorectal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Florida | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2017-03-30